PLRZ on Nasdaq

Polyrizon Ltd.

Polyrizon Ltd. is a surgical and medical instruments and apparatus company based in Raanana.1 Its shares trade on Nasdaq under the symbol PLRZ.1

Price unavailable

Last updated Oct 20, 2026.

Overview

-$3.3MNet income, fiscal 20252

Compare with another stock.

  • TickerPLRZ on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersL31
  • Incorporated inIsrael3
  • Business addressHapnina St 8, Ra'Anana, 43215453
  • Filer categoryNon-accelerated filer, Emerging growth company3
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Act regulating the solicitation of proxies, consents or authorizations with respect to a security registered under the Exchange Act;4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-15.9%Return on equity2
-$4.5MFree cash flow2

Financial statements

Operating income52-$6.2M in 2025+598% since 2022
-$8.0M-$6.0M-$4.0M-$2.0M02022: -$895.0K-$895.0K20222023: -$635.0K-$635.0K2023−29%2024: -$1.3M-$1.3M2024+105%2025: -$6.2M-$6.2M2025+380%
Net income52-$3.3M in 2025+328% since 2022
-$4.0M-$3.0M-$2.0M-$1.0M02022: -$779.0K-$779.0K20222023: -$600.0K-$600.0K2023−23%2024: -$1.5M-$1.5M2024+158%2025: -$3.3M-$3.3M2025+116%
Fiscal year20212022202320242025
Research and development$347.0K5$332.0K2$534.0K2$2.1M2
Operating income-$895.0K5-$635.0K2-$1.3M2-$6.2M2
Net income-$779.0K5-$600.0K2-$1.5M2-$3.3M2
Earnings per share$0.605$494.402$805.202$4.902
Earnings per share (diluted)$0.605$494.402$805.202$4.902
Shares (weighted, basic)1.3M shares51.4K shares22.0K shares2680.4K shares2
Shares (weighted, diluted)1.3M shares51.4K shares22.0K shares2680.4K shares2

Compare Polyrizon Ltd. with another company

Corporate structure

Polyrizon Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Polyrizon Ltd.

  • MMCAP International Inc. SPC Filed SCHEDULE 13G/A on Polyrizon Ltd., latest Aug 14, 2026 (2 filings since Apr 28, 2026)
  • Eli Zamir Filed SCHEDULE 13G on Polyrizon Ltd., latest Mar 16, 2026 (2 filings since Dec 12, 2025)
  • L.I.A. Pure Capital Ltd Filed SCHEDULE 13G/A on Polyrizon Ltd., latest Mar 9, 2026 (2 filings since Dec 12, 2025)
  • Tomer Izraeli Filed SCHEDULE 13G on Polyrizon Ltd., latest Mar 5, 2025
  • Polyrizon Ltd. L3

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Polyrizon Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$12.0K2 Dec 31, 2025$10.0K2 Dec 31, 2024+20.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.3M2 Dec 31, 2025$2.6M2 Dec 31, 2024−48.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$2.5M2 Dec 31, 2025$2.9M2 Dec 31, 2024−11.7%
Finite-lived intangibles, net$300.0K2 Dec 31, 2025$116.0K2 Dec 31, 2024+158.6%

Leadership

Who has led Polyrizon Ltd., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Tomer Izraeli2026–now

Chief financial officer

  1. Nir Benyosef2026–now
Board members and other officers (9)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Chief Financial OfficerNir Ben Yosef named Apr 23, 2026 to Sep 10, 202617

Timeline

  1. Mar 18, 2026New chief executive Tomer Izraeli becomes CEO7

Filings

196 filings to the SEC since October 2021: 3 annual reports, 15 insider forms, 7 large holders, 2 private raises, 169 other. The latest 20:

  1. Oct 7, 2026S-8 REGISTRATION STATEMENT EDGAR
  2. Oct 5, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Oct 1, 2026EFFECT EDGAR
  4. Sep 28, 2026F-1/A AMENDMENT NO. 1 TO FORM F-1 EDGAR
  5. Sep 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Sep 18, 2026F-1 REGISTRATION STATEMENT EDGAR
  7. Sep 10, 2026D EDGAR
  8. Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  10. Sep 4, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  11. Aug 20, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  12. Aug 14, 2026SCHEDULE 13G/A EDGAR
  13. Jul 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Jul 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Jun 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Jun 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. Jun 15, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  18. Jun 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  19. Jun 8, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  20. Jun 8, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR

The 196 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 0 buys and 6 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 31, 2026Izraeli TomerChief Executive OfficerSale500$11.85$5.9KForm 4
Mar 31, 2026Carmel LironDirectorSale942$12.36$11.6KForm 4
Mar 31, 2026Adler OzDirectorSale3,292$12.05$39.7KForm 4
Mar 30, 2026Carmel LironDirectorSale100$11.00$1.1KForm 4
Mar 30, 2026Izraeli TomerChief Executive OfficerSale3,900$10.90$42.5KForm 4
Mar 30, 2026Turgeman TidharChief Technology OfficerSale2,917$10.90$31.8KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 3, 2026Raised $4 million in a private offering of securities Form D: 1 investor so far Form D
  2. Apr 7, 2026Raised $3.5 million in a private offering of securities Form D: 1 investor so far Form D

SEC filer profile

How Polyrizon Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPolyrizon Ltd.1
  • CIK0001893645
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inIsrael4
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressHapnina St 8, Ra'Anana, 4321545, Israel1
  • Phone972-54-79796681
  • Shares outstanding1,608,266 shares as of Dec 31, 20254
  • AuditorBrightman Almagor Zohar & Co., Tel Aviv, Israel PCAOB ID 1197; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceJan 10, 20221
  • Filings196 in all: 6-K (71), CORRESP (27), UPLOAD (18), F-1/A (15), 3 (9), EFFECT (7), 4 (6), F-1 (5)1
    All 27 form types

    SCHEDULE 13G (5), DRS/A (4), DRSLTR (4), 424B5 (3), S-8 (3), 20-F (2), 424B4 (2), D (2), SCHEDULE 13G/A (2), SEC STAFF LETTER (2), 20-F/A (1), 424B3 (1), 8-A12B (1), CERT (1), DRS (1), F-3 (1), POS AM (1), RW (1), RW WD (1)

  • Latest filingsAnnual report (20-F) Mar 25, 2026

Securities registered for trading

ClassSymbolExchange
Ordinary Shares, no par value per sharePLRZNasdaq

From the cover page of the 20-F filed Mar 25, 2026 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21